MacroGenics Inc (MGNX) support and resistance · rev $39.6M
MacroGenics Inc (MGNX) is a biotechnology company listed on NASDAQ.
This page maps MacroGenics Inc (MGNX) support and resistance from cached range and valuation — not a live tape and not a trade alert.
Latest reported MGNX revenue for 2026-06-30 was $39.6M. Net income was -$17.3M. Revenue was up 90.4% from 2026-03-31 to 2026-06-30. MGNX currently screens at market cap $246.6M.
MGNX currently screens at market cap $246.6M. Round numbers near that cap and multiple often act as psychological resistance; prior-period revenue is the fundamental floor traders argue about.
A new MGNX 8-K or 10-Q can move the levels that matter more than a drawing on a chart.
Not investment advice. Use the MGNX quote page for the session range and the stock page for the full model.
Not investment advice.